We monitor social channels on behalf of pharma and biotech clients to identify potential adverse events and report them to the right people on time. Powered by Verbular PV, our purpose-built pharmacovigilance platform.
Verbular PV runs a structured, seven-step process for every potential adverse event we detect. Nothing is reported without human review. Nothing is missed because of manual oversight.
Verbular PV scans public social platforms and online communities for mentions of your products, flagging posts that may be relevant for safety review.
We monitor comments, DMs, and mentions across your brand's social pages, ensuring potential AEs posted directly to your channels are never missed.
Verbular PV surfaces posts that show indicators of a potential adverse event, separating them from general conversation for closer assessment.
Each candidate is checked against the four core elements required for a valid AE report: an identifiable patient, a suspect product, an adverse event, and a reporter.
Verbular PV structures the relevant details into a case record, ready for your safety team to review and act on.
No report goes out without human sign-off. Your safety contact reviews the case, makes any amendments, and approves before notification is sent.
Approved cases trigger immediate notification to your designated safety contacts, with a full end-of-shift summary saved for your records.
Verbular PV was designed by practitioners who have run social PV programmes for global pharma clients. The platform and service are built around the workflows your safety team already follows, with a clear audit trail at every step.
Request a demo →We’re currently in the testing phase and working with early partners. If your team handles social PV monitoring, we’d like to show you how we work.
Request a demo →